FDA Inspection 1102410 — Katja Sockel
The FDA completed an inspection of Katja Sockel on August 16, 2019 in Dresden. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 16, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dresden (Germany)
Additional Details
Clinical Investigator (CI)